Equity Profile
Post-Earnings Recap
Halozyme Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.86 | $2.67 | +6.56% |
| Revenue | — | $7.7B | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Applied Materials, Inc. (AMAT) is a leading provider of equipment and services used in the manufacturing of semiconductors....
EPS
Earnings per share (EPS) is a critical measure of profitability, and investors will be keen to see if AMAT can meet or exceed the consensus estimate.
Revenue
Total revenue gives insight into the company's overall performance and demand for its products, which is especially important in the current semiconductor market.
Wall Street expectations, options signals, track record, and call prep available with Pro.
Net selling
1 trade
Net buying
Recent Transactions
Traded Feb 27, 2026 · disclosed Mar 6, 2026
$1,001.00–$15,000.00
Traded Dec 29, 2025 · disclosed Jan 16, 2026
$15,001.00–$50,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.